The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors
Author:
Funder
FONDECYT (Chile)
Publisher
Informa UK Limited
Subject
Drug Discovery
Link
http://www.tandfonline.com/doi/pdf/10.1080/17460441.2016.1227317
Reference194 articles.
1. Network pharmacology: the next paradigm in drug discovery
2. Polypharmacology – Foe or Friend?
3. Shifting from the single to the multitarget paradigm in drug discovery
4. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective
5. Nicotinic ACh receptors as therapeutic targets in CNS disorders
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multi-target-based polypharmacology prediction (mTPP): An approach using virtual screening and machine learning for multi-target drug discovery;Chemico-Biological Interactions;2022-12
2. Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19;Frontiers in Pharmacology;2022-08-17
3. A New Strategy for Multitarget Drug Discovery/Repositioning Through the Identification of Similar 3D Amino Acid Patterns Among Proteins Structures: The Case of Tafluprost and its Effects on Cardiac Ion Channels;Frontiers in Pharmacology;2022-03-18
4. Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists;International Journal of Molecular Sciences;2021-11-08
5. NAChRDB: A Web Resource of Structure–Function Annotations to Unravel the Allostery of Nicotinic Acetylcholine Receptors;ACS Omega;2021-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3